Patients sue GLP-1 makers over sudden loss of vision

AI Summary

Patients in the United States are suing makers of GLP-1 drugs, alleging the companies failed to warn about a rare condition causing sudden vision loss. The lawsuit highlights concerns over pharmaceutical transparency and patient safety.

Patients say the pharmaceutical companies failed to warn them of a risk of a rare condition that causes vision loss.